tiprankstipranks
Trending News
More News >
Advertisement

VUSE - ETF AI Analysis

Compare

Top Page

VUSE

Vident Core US Equity Fund (VUSE)

Rating:75Outperform
Price Target:
$75.00
The VUSE ETF's overall rating reflects a strong foundation built on high-performing holdings like Visa and Meta Platforms, which contribute positively through exceptional financial performance and strategic advancements, particularly in AI and user engagement. However, weaker holdings such as AbbVie and Eli Lilly, with concerns around valuation and financial leverage, slightly temper the fund's overall score. A key risk factor is the ETF's exposure to high valuation metrics across several top holdings, which could impact future growth potential.
Positive Factors
Strong Top Holdings
Several top holdings, such as Oracle and Broadcom, have delivered strong year-to-date performance, supporting the fund’s overall returns.
Sector Diversification
The ETF is spread across multiple sectors, including technology, financials, and health care, reducing reliance on any single industry.
Healthy Year-to-Date Performance
The fund has shown solid year-to-date growth, indicating resilience in the current market environment.
Negative Factors
High Technology Exposure
With over 32% of the portfolio in technology, the fund is vulnerable to downturns in this sector.
Limited Geographic Exposure
The ETF is almost entirely focused on U.S. companies, offering little diversification across global markets.
Moderate Expense Ratio
The fund’s expense ratio is higher than some low-cost ETFs, which could slightly reduce long-term returns.

VUSE vs. SPDR S&P 500 ETF (SPY)

VUSE Summary

The Vident Core US Equity Fund (VUSE) is an ETF that gives investors access to a wide range of U.S. companies, from small startups to large, established firms. It follows the Vident Core U.S. Stock Index and includes well-known companies like Apple and Walmart. This ETF is designed for those looking for diversification across sectors like technology, healthcare, and consumer goods, making it a good option for long-term growth. However, new investors should know that its performance can fluctuate with the overall U.S. stock market, so it carries the risk of market ups and downs.
How much will it cost me?The Vident Core US Equity Fund (VUSE) has an expense ratio of 0.5%, which means you’ll pay $5 per year for every $1,000 invested. This is higher than average for ETFs because it uses an actively managed strategy that focuses on optimizing risk-adjusted returns through proprietary factors. Active management typically involves more research and decision-making, which can lead to higher costs.
What would affect this ETF?VUSE's heavy exposure to technology and consumer sectors could benefit from innovation and consumer spending trends, especially if economic conditions remain strong and interest rates stabilize. However, rising interest rates or regulatory changes in tech and healthcare could negatively impact its top holdings like Apple, Meta, and Eli Lilly. Additionally, broader economic slowdowns or sector-specific challenges could affect its diverse portfolio across U.S. equities.

VUSE Top 10 Holdings

VUSE leans heavily into technology, with names like Broadcom and Alphabet driving the fund’s performance thanks to their strong momentum in AI and cloud services. Apple adds steady growth to the mix, though its high valuation raises some caution. On the flip side, Oracle and Meta Platforms have shown mixed results, with Oracle’s cloud growth offset by leverage concerns and Meta facing regulatory hurdles. The fund’s U.S.-centric focus and broad sector exposure provide balance, but its tech-heavy tilt means the fund’s fortunes are closely tied to the sector’s ups and downs.
Name
Company Name
Weight %
Market Value
Market Cap
Yearly Gain
Overall Rating
Broadcom3.00%$19.72M$1.82T118.51%
76
Outperform
Walmart2.57%$16.93M$816.90B25.89%
75
Outperform
Alphabet Class A2.48%$16.28M$3.32T57.38%
80
Outperform
Meta Platforms2.39%$15.70M$1.89T27.01%
79
Outperform
Visa2.37%$15.57M$657.51B17.62%
75
Outperform
Oracle2.30%$15.11M$784.82B57.71%
66
Neutral
Apple2.25%$14.79M$4.00T17.21%
78
Outperform
Eli Lilly & Co2.14%$14.05M$769.97B-3.93%
70
Outperform
Nvidia2.12%$13.94M$5.03T48.59%
85
Outperform
AbbVie2.09%$13.77M$397.72B11.73%
64
Neutral

VUSE Technical Analysis

Technical Analysis Sentiment
Positive
Last Price
Price Trends
50DMA
65.89
Positive
100DMA
64.33
Positive
200DMA
61.46
Positive
Market Momentum
MACD
0.21
Positive
RSI
48.76
Neutral
STOCH
46.23
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For VUSE, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 66.31, equal to the 50-day MA of 65.89, and equal to the 200-day MA of 61.46, indicating a neutral trend. The MACD of 0.21 indicates Positive momentum. The RSI at 48.76 is Neutral, neither overbought nor oversold. The STOCH value of 46.23 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for VUSE.

VUSE Peer Comparison

Comparison Results
Name
Price
Price Target
AUM
Expense Ratio
Overall Rating
$652.39M0.50%
75
Outperform
$886.92M0.59%
68
Neutral
$823.48M0.60%
73
Outperform
$740.43M0.52%
74
Outperform
$739.30M0.27%
70
Outperform
$725.59M0.50%
77
Outperform
Performance Comparison
Ticker
Company Name
Price
Change
% Change
VUSE
Vident Core US Equity Fund
66.12
9.01
15.78%
SYLD
Cambria Shareholder Yield ETF
PLDR
Putnam Sustainable Leaders ETF
PFM
Invesco Dividend Achievers ETF
AUSF
Global X Adaptive U.S. Factor ETF
HLAL
Wahed FTSE USA Shariah ETF
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents
Advertisement